Diane M. Karl - Concepedia

Concepedia

Author

Diane M. Karl

Oregon Health & Science University

Also Known As

D Karl, D. Karl, D. M. KARL, D. M. Karl, Diane Karl, Diane M Karl, Diane M. Karl

18

Publications

1.8K

Citations

11

H-Index

35

Concepts

All Affiliations

Oregon Health & Science University Oregon Clinic Jacobi Medical Center Case Western Reserve University St Joseph's Health Care

DM

About

Diane M. Karl is an author at Oregon Health & Science University specializing in medicine, diabetes, and metabolic syndrome.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	6	6	1.6K
2	Diabetes	5	5	1.6K
3	Health Sciences	3	3	154
4	Public Health	2	2	1.5K
5	Endocrinology	2	2	87

Diane M. Karl

×

10

Publications

1.8K

Citations

10

H-Index

	Year	Citations
Effect of intensive treatment of hyperglycaemia on microvascular outcomes in type 2 diabetes: an analysis of the ACCORD randomised trial Faramarz Ismail‐Beigi, Timothy E. Craven, Mary Ann Banerji, The Lancet Metabolic SyndromeDiabetes ManagementHealth PolicyCardiovascular DiseaseDiabetes	2010	1.4K
Insulin Detemir Results in Less Weight Gain than NPH Insulin When??Used in Basal-Bolus Therapy for??Type??2 Diabetes??Mellitus, and this??Advantage Increases with Baseline??Body??Mass Index Katarina Ra lov, Søren C. Tamer, Per Clauson, Clinical Drug Investigation ObesityMetabolic SyndromeBody CompositionInsulin ManagementPhysiology	2007	69
Combined intensive blood pressure and glycemic control does not produce an additive benefit on microvascular outcomes in type 2 diabetic patients Faramarz Ismail‐Beigi, Timothy E. Craven, Patrick J. O’Connor, Kidney International Metabolic SyndromeHypertensionDiabetes ManagementCardiovascular DiseaseHealth Policy	2011	67
Albuminuria and Cognitive Decline in People with Diabetes and Normal Renal Function Joshua I. Barzilay, James Lovato, Anne M. Murray, Clinical Journal of the American Society of Nephrology	2013	65
Individualizing Targets and Tactics for High-Risk Patients With Type 2 Diabetes Matthew C. Riddle, Diane M. Karl Diabetes Care Metabolic SyndromeDiabetes ManagementDiabetes EpidemiologyCardiovascular DiseaseCardiometabolic Risk	2012	51
Pramlintide as An Adjunct to Insulin in Patients with Type 2 Diabetes in A Clinical Practice Setting Reduced A1C, Postprandial Glucose Excursions, And Weight Diane M. Karl, Athena Philis‐Tsimikas, Tamara Darsow, Diabetes Technology & Therapeutics	2007	39
Parathyroid Hormone Status and Renal Responsiveness in Familial Hypophosphatemic Rickets Theodore J. Hahn, Cheryl R. Scharp, Linda R. Halstead, The Journal of Clinical Endocrinology & Metabolism	1975	30
Clinical predictors of risk of hypoglycaemia during addition and titration of insulin glargine for type 2 diabetes mellitus Diane M. Karl, Jesjeet Singh Gill, Rong Zhou, Diabetes Obesity and Metabolism	2013	22
Human pharmacology and clinical evaluation of an oral carbenicillin preparation José L. Bran, Diane M. Karl, Donald Kaye Clinical Pharmacology & Therapeutics Healthy SubjectsUrinary Tract InfectionPharmacotherapyAntimicrobial ChemotherapyDrug Resistance	1971	22
Fasting hypoglycemia associated with disopyramide Jeffery D. Semel, Edward Wortham, Diane M. Karl American Heart Journal Metabolic SyndromeDiabetes ManagementMedicinePhysiologyDiabetes	1983	18

Page 1